marizomib and Triple-Negative-Breast-Neoplasms

marizomib has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for marizomib and Triple-Negative-Breast-Neoplasms

Article	Year
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition. Theranostics, 2020, Volume: 10, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Lactones; Mice; Oxidative Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrroles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2020

Article

Year

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.

Theranostics, 2020, Volume: 10, Issue:12

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Lactones; Mice; Oxidative Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrroles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2020